Letter to the Editor: Short-Term Outcomes of Aflibercept Therapy for Diabetic Macular Edema in Patients With Incomplete Response to Ranibizumab and/or Bevacizumab

被引：1
|
作者：
Calugaru, Dan [1 ]
Calugaru, Mihai [1 ]
机构：
[1] Univ Med, Dept Ophthalmol, Cluj Napoca, Romania
来源：
OPHTHALMIC SURGERY LASERS & IMAGING RETINA | 2017年 / 48卷 / 04期
关键词：
VEGF TRAP;
D O I：
10.3928/23258160-20170329-01
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：280 / 280
页数：1
相关论文
共 50 条
  • [21] Treatment of Diabetic Macular Edema with Aflibercept in Eyes with Previous Nonresponse to Ranibizumab and/or Bevacizumab
    Sadowsky, Rachel
    Quiram, Polly
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [22] Clinical Outcomes of Eyes With Diabetic Macular Edema Switched From Aflibercept to Ranibizumab Therapy
    Mellen, Phoebe L.
    Obeid, Anthony
    Wibbelsman, Turner D.
    Hsu, Jason
    Konkoly, Michelle A.
    Velez, Michael R.
    Calem, Daniel B.
    Sioufi, Kareem
    Jenkins, Thomas L.
    Xu, David
    Chiang, Allen
    Gupta, Omesh P.
    Spirn, Marc
    Regillo, Carl D.
    Ho, Allen C.
    Klufas, Michael A.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2020, 51 (12): : 691 - 697
  • [23] Short-term effect of aflibercept on visual acuity and central macular thickness in patients not responding to ranibizumab and bevacizumab
    Maksys, Sandra
    Richter-Mueksch, Sibylla
    Weingessel, Birgit
    Vecsei-Marlovits, Pia Veronika
    WIENER KLINISCHE WOCHENSCHRIFT, 2017, 129 (9-10) : 351 - 357
  • [24] Short-term effect of aflibercept on visual acuity and central macular thickness in patients not responding to ranibizumab and bevacizumab
    Sandra Maksys
    Sibylla Richter-Müksch
    Birgit Weingessel
    Pia Veronika Vécsei-Marlovits
    Wiener klinische Wochenschrift, 2017, 129 : 351 - 357
  • [25] Faricimab for Diabetic Macular Edema in Patients Refractory to Ranibizumab or Aflibercept
    Ohara, Hiromi
    Harada, Yosuke
    Hiyama, Tomona
    Sadahide, Ayako
    Minamoto, Akira
    Kiuchi, Yoshiaki
    MEDICINA-LITHUANIA, 2023, 59 (06):
  • [26] Macular Ischemia Changes in Patients with Diabetic Macular Edema Treated with Aflibercept and Ranibizumab
    Maris, Dimitrios
    Dastiridou, Anna
    Kotoula, Maria
    Karathanou, Aikaterini
    Tsironi, Evangelia E.
    Bargiota, Alexandra
    Androudi, Sofia
    DIAGNOSTICS, 2024, 14 (12)
  • [27] Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema: Exploratory Retrospective Analysis
    Pessoa, Bernardete
    Malheiro, Luisa
    Carneiro, Ines
    Monteiro, Silvia
    Coelho, Joao
    Coelho, Constanca
    Figueira, Joao
    Meireles, Angelina
    Melo Beirao, Joao Nuno
    CLINICAL OPHTHALMOLOGY, 2021, 15 : 253 - 260
  • [28] Short-Term Clinical Outcomes of Patients with Diabetic Macular Edema Following a Therapy Switch to Faricimab
    Wolfrum, Peter
    Boehm, Elsa Wilma
    Lorenz, Katrin
    Stoffelns, Bernhard
    Pfeiffer, Norbert
    Korb, Christina A.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (15)
  • [29] The Short-Term Efficacy of Biweekly Subconjunctival Bevacizumab in Diabetic Macular Edema
    Yeter, Volkan
    Yucel, Ozlem Eski
    Birinci, Hakke
    CURRENT EYE RESEARCH, 2020, 45 (05) : 585 - 590
  • [30] SHORT-TERM FLUCTUATION OF DIABETIC MACULAR EDEMA AFTER INTRAVITREAL RANIBIZUMAB INJECTION
    Querques, Giuseppe
    Bux, Anna V.
    Martinelli, Domenico
    Iaculli, Cristiana
    Del Curatolo, Maria V.
    Delle Noci, Nicola
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2009, 29 (09): : 1274 - 1281
12345